How to interpret surrogate markers of efficacy in osteoporosis
- PMID: 15940381
- DOI: 10.1359/JBMR.050217
How to interpret surrogate markers of efficacy in osteoporosis
Comment on
-
Treatment with once-weekly alendronate 70 mg compared with once-weekly risedronate 35 mg in women with postmenopausal osteoporosis: a randomized double-blind study.J Bone Miner Res. 2005 Jan;20(1):141-51. doi: 10.1359/JBMR.040920. Epub 2004 Sep 29. J Bone Miner Res. 2005. PMID: 15619680 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources

